Lake Street Initiates Coverage On Alterity Therapeutics with Buy Rating, Announces Price Target of $10
Lake Street analyst Thomas Flaten initiates coverage on Alterity Therapeutics (NASDAQ:ATHE) with a Buy rating and announces Price Target of $10.
A research company called Lake Street started following Alterity Therapeutics and thinks it looks good. This can hint that the company might have something promising, but the stock could move either way.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.